We study early-onset cancer diagnosed before age 50 years.
Our paper (2021) in Nature Reviews Clinical Oncology (that proposes integrative research approaches including molecular pathological epidemiology and the age continuum concept) https://pubmed.ncbi.nlm.nih.gov/33219329/
Our study (2021) on LINE-1 hypomethylation in early-onset colorectal cancer. Findings suggest the age continuum concept. https://pubmed.ncbi.nlm.nih.gov/33922024/
Our study (2021) is the first comprehensive study of immune cell infiltrates in early-onset colorectal cancer, using multispectral immunofluorescence assays. https://pubmed.ncbi.nlm.nih.gov/34529108/
We have published a number of studies on risk factors in early-onset colorectal cancer and adenomas since 2015.
